Ameriprise Financial Inc. decreased its position in shares of Axcelis Technologies Inc (NASDAQ:ACLS) by 35.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,129 shares of the semiconductor company’s stock after selling 27,609 shares during the period. Ameriprise Financial Inc.’s holdings in Axcelis Technologies were worth $1,398,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACLS. Royal Bank of Canada grew its stake in shares of Axcelis Technologies by 391.3% during the second quarter. Royal Bank of Canada now owns 4,913 shares of the semiconductor company’s stock valued at $103,000 after buying an additional 3,913 shares during the last quarter. Advisor Group Inc. grew its stake in shares of Axcelis Technologies by 143.7% during the third quarter. Advisor Group Inc. now owns 3,985 shares of the semiconductor company’s stock valued at $109,000 after buying an additional 2,350 shares during the last quarter. J.P. Marvel Investment Advisors LLC bought a new position in shares of Axcelis Technologies during the second quarter valued at about $220,000. Voya Investment Management LLC bought a new position in shares of Axcelis Technologies during the second quarter valued at about $271,000. Finally, Navellier & Associates Inc bought a new position in shares of Axcelis Technologies during the second quarter valued at about $379,000. Institutional investors and hedge funds own 77.95% of the company’s stock.
Shares of Axcelis Technologies Inc (NASDAQ:ACLS) opened at $31.05 on Wednesday. The stock has a market capitalization of $969.50, a PE ratio of 26.09, a P/E/G ratio of 0.86 and a beta of 1.10. Axcelis Technologies Inc has a 12 month low of $14.55 and a 12 month high of $37.05.
In related news, EVP John E. Aldeborgh sold 87,500 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $33.22, for a total value of $2,906,750.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Kevin J. Brewer sold 44,640 shares of the firm’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $33.93, for a total value of $1,514,635.20. The disclosure for this sale can be found here. Insiders sold 190,190 shares of company stock worth $6,334,389 over the last three months. 5.66% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This report was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.themarketsdaily.com/2018/01/10/ameriprise-financial-inc-lowers-holdings-in-axcelis-technologies-inc-acls.html.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training.
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies Inc (NASDAQ:ACLS).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.